弹性体输液帮浦市场规模、份额和成长分析(按产品、应用、最终用途和地区划分)—产业预测(2026-2033 年)
市场调查报告书
商品编码
1898453

弹性体输液帮浦市场规模、份额和成长分析(按产品、应用、最终用途和地区划分)—产业预测(2026-2033 年)

Elastomeric Infusion Pumps Market Size, Share, and Growth Analysis, By Product (Continuous Rate EIP, Variable Rate EIP), By Application (Pain Management, Antibiotic/Antiviral Therapy), By End Use, By Region -Industry Forecast 2026-2033

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计到 2024 年,弹性输液帮浦市场规模将达到 7.3454 亿美元,从 2025 年的 7.8816 亿美元成长到 2033 年的 13.8488 亿美元,在预测期(2026-2033 年)内复合年增长率为 7.3%。

弹性体输液帮浦市场受到糖尿病、心血管疾病和癌症等慢性疾病日益普遍的显着影响,这些疾病是全球主要的死亡原因。人们越来越重视有效的疾病管理,这推动了对弹性体帮浦等持续给药系统的需求。推动该市场发展的关键因素之一是居家医疗解决方案需求的不断增长。这些设备为那些希望在家接受治疗的患者提供了便利性和易用性。此外,人口老化导致的长期照护需求也是推动这一趋势的重要因素。为了促进市场成长,製造商正在不断创新弹性体帮浦技术,以提高输注精度、延长输注时间并增强功能,从而在确保可靠性的同时,满足不同患者和医疗保健专业人员的需求。

弹性体输液帮浦市场驱动因素

全球弹性体输液帮浦市场的主要驱动因素之一是慢性疾病的日益普遍,这些疾病需要先进且有效的治疗方案。糖尿病、癌症和疼痛管理等疾病需要持续给药,导致对可靠易用的输液解决方案的需求激增。弹性体输液帮浦具有许多优势,包括易于使用、便于携带以及降低併发症风险,使其成为传统方法的理想替代方案。此外,居家医疗和门诊护理模式的不断普及,以及输液帮浦能够实现持续给药,也正在推动市场成长。

限制弹性体输液帮浦市场的因素

全球弹性体输液帮浦市场的主要限制因素之一是人们对药物输送系统的安全性和准确性日益增长的担忧。医疗专业人员越来越警惕输液帮浦可能出现的错误,例如药物剂量计算错误或机械故障,这些都可能导致严重的患者併发症。医疗设备严格的监管要求进一步加剧了这种担忧,迫使製造商投入大量资金进行研发以改善安全性能。因此,高成本和漫长的核准流程可能会阻碍新进者,并限制弹性体输液帮浦领域的创新和扩张机会。

弹性体输液帮浦市场趋势

弹性体输液帮浦市场正呈现出显着的数位化医疗解决方案整合趋势,旨在打造混合模式以提升患者照护。传统弹性体输液帮浦与远端医疗平台和智慧型手机应用程式的融合,透过即时监测和输液调整,显着提高了治疗的准确性和效率。这种整合不仅使医护人员能够远端监测输液过程,从而提升了护理标准,而且还能够在必要时进行即时干预,从而增强了患者安全。因此,随着人们对便利高效的医疗解决方案的需求日益增长,弹性体输液帮浦在居家医疗领域也越来越受欢迎。

目录

介绍

  • 调查目标
  • 定义
  • 市场覆盖范围

调查方法

  • 资讯收集
  • 二手和一手资讯来源
  • 市场规模预测
  • 市场假设与限制

执行摘要

    前景
  • 供需趋势分析
  • 细分市场机会分析

市场动态与展望

  • 市场动态
    • 司机
    • 机会
    • 抑制因素
    • 任务
  • 波特分析

关键市场考察

  • 技术分析
  • 价值链分析
  • 市场生态系统
  • 用例分析
  • 监管环境
  • 创新矩阵
  • 主要投资分析
  • 关键成功因素
  • 竞争程度

按产品分類的弹性体输液帮浦市场

  • 恆速弹性体注射泵
  • 变速弹性体输液泵

按应用分類的弹性体输液帮浦市场

  • 疼痛管理
  • 化疗
  • 抗生素/抗病毒治疗
  • 其他的

按最终用途分類的弹性体输液帮浦市场

  • 医院
  • 门诊手术中心
  • 其他的

按地区分類的弹性体输液帮浦市场规模

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • GCC
    • 南非
    • 其他中东和非洲地区

竞争格局

  • 前五大公司对比
  • 主要企业的市场定位(2025 年)
  • 主要市场参与者所采取的策略
  • 近期市集活动
  • 主要企业市占率(2025 年)

主要企业简介

  • 百特(美国)
  • 费森尤斯卡比股份公司(德国)
  • B. Braun SE(德国)
  • Ambu A/S(丹麦)
  • NIPRO(日本)
  • 泰尔茂株式会社(日本)
  • AVNS(美国)
  • 维贡集团(法国)
  • 史密斯集团有限公司(英国)
  • ICU Medical, Inc.(美国)
  • Pajunk GmbH(德国)
  • 宇荣医疗有限公司(韩国)
  • 蓝宝石医疗(以色列)
  • 艾斯医疗有限公司(韩国)
  • 伊坦医疗(以色列)
  • Zyno Medical(美国)
  • Epic Medical(新加坡)
  • 日本尼普洛株式会社
  • 大研医疗株式会社(日本)
  • Coopdech(日本)
  • Westmed公司(美国)
  • Flowonix Medical Inc.(美国)
简介目录
Product Code: SQMIG35A2679

Elastomeric Infusion Pumps Market size was valued at USD 734.54 Million in 2024 and is poised to grow from USD 788.16 Million in 2025 to USD 1384.88 Million by 2033, growing at a CAGR of 7.3% during the forecast period (2026-2033).

The elastomeric infusion pumps market is significantly influenced by the rising prevalence of chronic diseases such as diabetes, cardiovascular issues, and cancer, which are major contributors to global mortality. This increased focus on effective disease management has led to a growing demand for continuous medication delivery systems like elastomeric pumps. A pivotal factor driving this market is the escalating need for home healthcare solutions, as these devices offer mobility and ease of use for patients preferring treatment in their homes. Furthermore, the aging population's need for long-term care supports this trend. To enhance market growth, manufacturers are innovating elastomeric pump technology to improve accuracy, extend infusion durations, and develop better functionalities, ensuring reliability while meeting diverse patient and healthcare professional requirements.

Top-down and bottom-up approaches were used to estimate and validate the size of the Elastomeric Infusion Pumps market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Elastomeric Infusion Pumps Market Segments Analysis

Global Elastomeric Infusion Pumps Market is segmented by Product, Application, End Use, and region. Based on Product, the market is segmented into Continuous Rate Elastomeric Infusion Pumps, and Variable Rate Elastomeric Infusion Pumps. Based on function, the market is segmented into Pain Management, Chemotherapy, Antibiotic/Antiviral Therapy, and Others. Based on End Use, the market is segmented into Hospitals, Ambulatory Surgical Centers, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Elastomeric Infusion Pumps Market

One of the key market drivers for the global elastomeric infusion pumps market is the increasing prevalence of chronic diseases, necessitating advanced and effective treatment options. As conditions such as diabetes, cancer, and pain management require consistent medication delivery, the demand for reliable and user-friendly infusion solutions has surged. Elastomeric infusion pumps offer several advantages, including ease of use, portability, and reduced risk of complications, making them an attractive alternative to traditional methods. Furthermore, the ongoing shift towards home healthcare and outpatient treatment settings aligns with the infusion pump's ability to provide continuous drug delivery, propelling market growth.

Restraints in the Elastomeric Infusion Pumps Market

One significant market restraint for the global elastomeric infusion pumps market is the growing concern over safety and accuracy in medication delivery systems. Healthcare providers are increasingly wary of potential errors associated with infusion pumps, such as drug miscalculations or mechanical failures, which can lead to severe patient complications. This concern is further amplified by stringent regulatory requirements for medical devices, prompting manufacturers to invest heavily in research and development for improved safety features. Consequently, the high costs and lengthy approval processes may inhibit the entry of newer players, limiting innovation and expansion opportunities in the elastomeric infusion pump sector.

Market Trends of the Elastomeric Infusion Pumps Market

The Elastomeric Infusion Pumps market is witnessing a significant trend towards the integration of digital health solutions, creating a hybrid model that enhances patient care. The convergence of telemedicine platforms and smartphone applications with traditional elastomeric pumps offers improved therapy accuracy and efficiency through real-time monitoring and infusion adjustments. This integration not only elevates the standard of care by enabling healthcare professionals to remotely oversee infusion processes but also enhances patient safety, allowing for immediate intervention when necessary. As a result, elastomeric infusion pumps are gaining traction in home care environments, aligning with the increasing demand for accessible and efficient healthcare solutions.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Technology Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • Case study Analysis
  • Regulatory Landscape
  • Innovation Matrix
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Elastomeric Infusion Pumps Market by Product

  • Market Overview
  • Continuous Rate Elastomeric Infusion Pumps
  • Variable Rate Elastomeric Infusion Pumps

Elastomeric Infusion Pumps Market by Application

  • Market Overview
  • Pain Management
  • Chemotherapy
  • Antibiotic/Antiviral Therapy
  • Others

Elastomeric Infusion Pumps Market by End Use

  • Market Overview
  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Elastomeric Infusion Pumps Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2025

Key Company Profiles

  • Baxter (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fresenius Kabi AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun SE (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ambu A/S (Denmark)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NIPRO (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AVNS (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vygon Group (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Smiths Group plc (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ICU Medical, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pajunk GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Woo Young Medical Co., Ltd. (South Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sapphire Medical (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ace Medical Co., Ltd. (South Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eitan Medical (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zyno Medical (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Epic Medical (Singapore)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nipro Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Daiken Medical Co., Ltd. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Coopdech (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Westmed, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Flowonix Medical Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments